Our full-service logistics and cell and gene therapy storage solutions help you seamlessly deliver innovation
Cell and gene therapy (CGT) logistics must overcome critical challenges that historically have affected the global cell therapy supply chain. Complex cell therapy logistics require precise temperature control and time-sensitive delivery. Explore how World Courier's cutting-edge solutions streamline these processes to ensure the safe and efficient transport of these groundbreaking therapies. Discover how we are revolutionizing the CGT supply chain as an advanced therapy logistics provider. Learn more about our comprehensive services and global expertise:
- An introduction to CGT
- CGT logistics solutions
- CGT supply chain challenges
- The World Courier difference
What is cell and gene therapy – and how does the supply chain work?
Cell and gene therapies (CGTs) represent the leading edge of biomedical research. Autologous and allogeneic cell, gene, and tissue therapies are transforming healthcare. Approvals of autologous CAR-T therapies such as Kymriah, Tecartus, and Yescarta and allogeneic treatments including Rethymic and Alofisel reinforce the advancements in this space.
CGT sponsors must consider every aspect of their development and manufacturing journey as early as possible to ensure their discovery therapy can be approved and commercialized without delay.
Planning for all stages of cell therapy logistics — including development, clinical trials, and commercialization — is a crucial part of this process. However, CGTs come with unique logistic requirements that add complexity and risk to their supply chains. Understanding the end-to-end supply chain of CGTs early ensures risks are mitigated before they cause delays in getting treatment to patients. Key aspects of a robust cold supply chain:
- Global real-time temperature and location monitoring
- 24/7 support
- Compliance support for import/export requirements special handling requirements
- Cryogenic packaging, storage, and transportation
Providing cell and gene therapy logistics solutions
World Courier is a trusted partner in the cell and gene therapy supply chain, offering specialized solutions tailored to your needs. We have over five decades of experience in specialty logistics and have been transporting CGTs since 2005.
At World Courier, we have made a name for ourselves through our white-glove service of gene and cell therapy shipping. Our dedicated cell and gene therapy logistics team is reinforced by years of industry knowhow that covers the entire cell therapy supply chain.
Supporting advanced therapy solutions
Temperature-controlled solutions for cell and gene therapy storage
Quality systems
Rising to the cell and gene therapy supply chain challenge
Global cryogenic charging locations
To support the growth of the advanced therapy solutions industry and enable more patients than ever before to be treated with these life-changing therapies, World Courier can charge across its network of more than 120+ offices globally.
Through this global network, we help advanced therapy companies build robust logistics platforms that support the clinical development and commercialization of therapies to meet patient treatment needs.
Solutions that grow with your needs
The World Courier difference
Dependable cold chain solutions in cell therapy
World Courier delivers dependable cold chain logistics in cell therapy, ensuring temperature sensitive materials remain protected from initial collection through final delivery. Our solutions are designed to manage controlled and cryogenic requirements across every handoff, combining qualified packaging, real time monitoring, and expert handling. This integrated approach safeguards product integrity throughout transport, supporting time critical cell therapy shipping while maintaining strict temperature compliance across the supply chain.
Working with our partners
Why choose World Courier for your cell and gene therapy logistics?
World Courier combines deep expertise in cell and gene therapy logistics with a global infrastructure built to support the most complex, time‑ and temperature‑sensitive therapies. Our solutions are designed to protect product integrity at every stage of the supply chain, from cryogenic preservation and controlled transport to final delivery.
With a worldwide network of LN₂ charging centres, licensed cryogenic facilities, and trained specialists, we support reliable cell therapy shipping and cold chain execution across clinical and commercial programmes. Backed by robust quality systems and strong regulatory compliance, we help reduce risk, improve consistency, and give partners confidence as their therapies scale globally.
Global LN2 charging capability
Our pharmaceutical delivery credentials
World Courier is a trusted provider of cell therapy supply chain management, with the regulatory compliance history and credentials to prove it.
By prioritizing quality, we also go beyond baseline compliance to optimize the cell therapy supply chain for our customers and their patients. Our teams ensure regulatory compliance and mitigate risks through training and communication. By engaging stakeholders on a shipment-by-shipment basis, we deliver quality that exceeds minimum requirements. Trust us for secure and compliancy throughout your commercialization journey.
Other international guidelines we adhere to:
- GDP compliant
- National and State Board of Pharmacy licensed (where applicable)
- WHO good distribution practices for pharmaceutical products, TRS No. 957 Annex 5
- EU guidelines on good distribution practice of medicinal products for human use (2013/C 343/01)
- USP <1079> Good Storage and Shipping Practices for Drug Products, US Pharmacopeia
- Code of Federal Regulations (CFR) 21 Part 11 compliant.
Cell and gene therapy FAQs
Are CGTs dangerous goods?
How do you ensure CGTs stay within the right temperature range?
How have cell and gene therapies evolved?
Why are CGTs so crucial today?
Cell and gene therapies are crucial because they offer a cutting edge approach to treating diseases. They offer personalized treatments for conditions like cancer and genetic disorders, holding the potential to revolutionize healthcare. With fewer side effects and the ability to address the causes of illnesses, these therapies offer new hope for patients who had limited options in the past, providing a path towards better outcomes and improved quality of life.
